PRESS: Celadon Pharmaceuticals Plc is preparing to become the provider of medical-grade cannabis for a 5,000 UK patient trial

There has been an excellent article published in The Times today about the groundbreaking 5,000 patient trial by one of our subsidiary companies LVL Health Medical Cannabis Clinic to study the use of medicinal cannabis to treat chronic pain.
Celadon Pharmaceuticals Plc is getting ready to become the provider of medical-grade cannabis for the trial grown here in the UK. Celadon has recently become the first medical cannabinoid company to float on the AIM London Stock Exchange since GW Pharma.
OTHER POSTS
-
PRESS: British Pain Society features Celadon Pharmaceuticals Plc
-
BUSINESS UPDATE: Celadon Pharmaceuticals Plc (CEL) Announces Interim Results
-
PRESS: Inside huge top-secret legal cannabis facility hidden away in Birmingham that is the size of three football pitches
-
PRESS: Celadon Pharmaceutical’s CEO Jim Short featured discussing new MHRA framework